A detailed history of Trustmark National Bank Trust Department transactions in Abbott Laboratories stock. As of the latest transaction made, Trustmark National Bank Trust Department holds 10,989 shares of ABT stock, worth $1.27 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
10,989
Previous 12,194 9.88%
Holding current value
$1.27 Million
Previous $1.27 Million 1.18%
% of portfolio
0.09%
Previous 0.1%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$100.07 - $118.13 $120,584 - $142,346
-1,205 Reduced 9.88%
10,989 $1.25 Million
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $75,547 - $84,330
-750 Reduced 5.79%
12,194 $1.27 Million
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $134,600 - $148,659
1,229 Added 10.49%
12,944 $1.47 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $23,882 - $28,655
-250 Reduced 2.09%
11,715 $1.13 Million
Q2 2023

Aug 10, 2023

SELL
$100.78 - $112.29 $100,780 - $112,290
-1,000 Reduced 7.71%
11,965 $1.3 Million
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $57,765 - $70,730
-500 Reduced 3.71%
12,965 $1.83 Million
Q2 2021

Aug 11, 2021

SELL
$105.79 - $124.53 $84,420 - $99,374
-798 Reduced 5.59%
13,465 $1.56 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $11,972 - $14,105
-110 Reduced 0.77%
14,263 $1.71 Million
Q2 2020

Aug 12, 2020

SELL
$76.57 - $98.0 $306,280 - $392,000
-4,000 Reduced 21.77%
14,373 $1.31 Million
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $6,282 - $9,186
100 Added 0.55%
18,373 $1.45 Million
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $147,677 - $164,399
-1,881 Reduced 9.33%
18,273 $1.59 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $197,152 - $213,774
2,409 Added 13.58%
20,154 $1.69 Million
Q2 2019

Aug 13, 2019

SELL
$72.88 - $85.0 $32,723 - $38,165
-449 Reduced 2.47%
17,745 $1.49 Million
Q1 2019

May 13, 2019

SELL
$66.22 - $80.06 $2,317 - $2,802
-35 Reduced 0.19%
18,194 $1.46 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $171,570 - $194,364
-2,617 Reduced 12.55%
18,229 $1.32 Million
Q3 2018

Feb 22, 2019

SELL
$60.81 - $73.36 $1.57 Million - $1.9 Million
-25,844 Reduced 55.35%
20,846 $1.53 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $1.65 Million - $1.99 Million
27,174 Added 139.24%
46,690 $3.43 Million
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $21,588 - $23,827
375 Added 1.96%
19,516 $1.19 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $44,959 - $50,832
-799 Reduced 4.01%
19,141 $1.15 Million
Q3 2017

Nov 09, 2017

BUY
$48.06 - $53.64 $958,316 - $1.07 Million
19,940
19,940 $1.06 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Trustmark National Bank Trust Department Portfolio

Follow Trustmark National Bank Trust Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustmark National Bank Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Trustmark National Bank Trust Department with notifications on news.